Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,246 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)

NCT07153445

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Hospital General Universitario Dr. Balmis de Alicante Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
View all 21 locations
View Trial Details
Recruiting

PALACE: Cemiplimab Trial According to ctDNA Levels

NCT06917573

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Hospital General de Alicante Alicante, Spain
  • Hospital General de Elche Elche, Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 20 locations
View Trial Details
Recruiting

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

NCT07027514

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Community Health Network Indianapolis, Indiana, United States
  • Barbara Ann Karmanos Cancer Hospital Detroit, Michigan, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Recruiting

A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR Mutation

NCT07231068

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, China
  • Henan Provincial Cancer Hospital Zhengzhou, China
View Trial Details

Related conditions